The protein levels of COL1A1, ACTA2, MMP13, as well as mRNA levels of Col1a1, Acta2, Mmp13, were lower in BLM + OM-MSC treatment group as compared with BLM treatment group (Fig. 2H-N). The gene discussed is COL1A1; the disease is Bloom syndrome.